Bo Crouse-Feuerhelm Appointed President, Strategic Development, Americas and a Director on DPS Management Board

BOSTON, June 14, 2017 /PRNewswire/ -- DPS, the global architecture, design and engineering firm serving the life sciences industry, has announced the appointment of Bo Crouse-Feuerhelm as President of Strategic Development, Americas and a Director on the DPS Management Board.

Crouse-Feuerhelm joins DPS from M+W U.S. Inc., where for the past two years she has held the position of Vice President, with responsibility for leading a $200 million plus business serving the life sciences industry.

In her new position with DPS, Crouse-Feuerhelm will report directly to DPS CEO Frank Keogh. "This is a key senior appointment as we seek to grow the DPS business in the U.S. life sciences market.  Bo has an extensive industry network spanning the pharma, biotech, chemicals and consumer goods sectors. She has an outstanding track record, having held senior leadership roles in industry leading consulting, design and construction organizations. In her most recent role, Bo led several national and international growth initiatives," Keogh added.

Commenting on her appointment, Crouse-Feuerhelm said: "I'm very excited to be taking on this new and very challenging role with DPS and look forward to working with the team to deliver on the group's strategic plan in the Americas market. I have been very impressed with how DPS has grown its business globally in the past few years and look forward to helping the group build on this growth in the years ahead."

About DPS
DPS is a leading architecture, design and engineering firm with a focus on the life sciences and semiconductor sectors. DPS delivers services for clients across the complete engineering and construction value chain, including feasibility studies, concepts, architecture, engineering, procurement, construction management, commissioning, qualification and validation.

DPS applies its extensive process engineering expertise built over 40+ years, as well as significant lean construction experience, to assist clients in high-end process sectors such as pharmaceuticals, biotech, medical devices and semiconductors and to deliver their manufacturing facilities speedily, safely and cost effectively.

DPS employs more than 1,200 people in offices and client sites in Ireland, Netherlands, Belgium, Israel, Singapore, the United Kingdom, and the United States. For more information, visit www.dpsgroupglobal.com.

SOURCE DPS